Diaceutics PLC generates strong and growing annual revenues driven by widespread global adoption of its DXRX precision medicine data analytics platform and laboratory network services. Recent full-year financial results reflect robust top-line momentum, with annual revenues climbing to approximately £38.4 million (or over $50 million in trailing twelve-month USD equivalents), propelled by long-term data service contracts with major life science companies.